Skip To Content

Achromatopsia

Tube injecting medicine into vials
New Gene Therapy Clinical Trials for Achromatopsia

At Fighting Blindness Canada, we are committed to accelerating the development of new sight-saving treatments for a variety of blinding eye diseases. Clinical trials are an essential step in developing those treatments,…

Read More
Group of speakers from Vancouver Vision Quest 2019
The Era of Gene Therapy – A Panel Discussion

In this panel discussion from Vision Quest Vancouver on April 27, 2019, experts from around the world introduced the new era of gene therapy and discussed what this means for the future…

Read More
Young girl wearing eSight glasses holding cards in her hand playing with a man
GIVEAWAY: Win an eSight Device at Vision Quest!

Fighting Blindness Canada is giving away a fully calibrated eSight device to celebrate Vision Quest! eSight is a revolutionary pair of electronic glasses which enhance sight for low-vision users. Developed in Canada,…

Read More
1
FDA Rules Against For-Profit Stem Cell Company

Quick on the heels of last week’s Washington Post article discussing the dangers of stem cell therapy, a U.S. federal judge ruled in favour of the Food and Drug Administration (FDA) in…

Read More
image is of a microscope
FROM FOUNDATION TO FIGHTER

A LETTER FROM THE PRESIDENT AND CEO For 45 years, the Foundation Fighting Blindness has raised and directed critical funding into sight-saving research for blinding eye diseases. From our earliest days as…

Read More
7
Together We Will Cure Blindness

Right now, over one million Canadians are living with blinding eye diseases and as vision fades, so too can hope. To date, donors of the Fighting Blindness Canada (FBC) have contributed more…

Read More

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.

I have read and accepted the privacy policy